Wed, March 26, 2025
[ Wed, Mar 26th ]: NextBigFuture
Solving Robotaxi and Humanoid Bots in 2026 Will Prove Yann LeCun is Wrong
[ Wed, Mar 26th ]: VietNamNet
Vietnamese universities develop conversion formulas for 2025 admissions
[ Wed, Mar 26th ]: AZoLifeSciences
EMBL Scientists Observe DNA Looping Process in High Resolution
Tue, March 25, 2025
[ Tue, Mar 25th ]: Sportschosun
High school textbook Dokdo claims Japanese territory...Professor Seo Kyung-duk crossed the line
[ Tue, Mar 25th ]: MyChesCo
America's Students Deserve Better! Groundbreaking .. ill Passes House to Secure Future Competitiveness
[ Tue, Mar 25th ]: CNN
Listen to the first recorded evidence of a rig shark producing sound
[ Tue, Mar 25th ]: Hub
Parker Solar Probe team wins Collier Trophy
[ Tue, Mar 25th ]: Chosunbiz
NST launches platform to boost technology commercialization in South Korea
[ Tue, Mar 25th ]: AZoNano
Breakthrough Nano Material Uses Sunlight to Tackle Pollution and Produce Energy
[ Tue, Mar 25th ]: TechCrunch
Bill Gates-backed Commonwealth Fusion Systems hits key reactor construction milestone
[ Tue, Mar 25th ]: Newsweek
Chewing Gum Releases Microplastics Into Your Mouth, Scientists Warn
[ Tue, Mar 25th ]: Fortune
'I'm not trying to turn GSK into Google': How GSK .. ansformed the pharma giant into a tech powerhouse
[ Tue, Mar 25th ]: AlphaGalileo
UC3M brings almost a dozen informative proposals .. e Fair. Thursday, March 27 in Pavilion 1 of IFEMA
[ Tue, Mar 25th ]: AZOM
Flavor Science: Why Plant-Based Sausages Don't Quite Smell Like Meat
[ Tue, Mar 25th ]: STAT
Trump picks Susan Monarez to run the CDC
[ Tue, Mar 25th ]: NextBigFuture
Tesla China Domestic Sales Higher Than Last Year
[ Tue, Mar 25th ]: Digit
Engineering Head At Elon Musk's X 'Suddenly' Quits, Here's Why
[ Tue, Mar 25th ]: Wired
Using Starlink Wi-Fi in the White House Is a Slippery Slope for US Federal IT
[ Tue, Mar 25th ]: NDTV
IIIT Delhi Launches BTech In Computer Science And Economics
Mon, March 24, 2025
[ Mon, Mar 24th ]: KPBS
23andMe is filing for bankruptcy. Here's what it means for your genetic data
[ Mon, Mar 24th ]: TribLive
Covid spurred both public health advances and science skepticism
[ Mon, Mar 24th ]: UPI
Trump elevates Susan Monarez as nominee for CDC director
[ Mon, Mar 24th ]: Mumbrella
IAB Executive Technology Council unveils new chair
[ Mon, Mar 24th ]: PennLive
Harrisburg University's bond rating downgraded again
[ Mon, Mar 24th ]: Reuters
Trump to nominate Susan Monarez to lead US CDC, CBS News reports
[ Mon, Mar 24th ]: Wired
The Chaos of NIH Cuts Has Left Early-Career Scientists Scrambling
[ Mon, Mar 24th ]: Nature
What CERN does next matters for science and for international cooperation
[ Mon, Mar 24th ]: devdiscourse
Discrepancies in Government Statements on India's First Science Policy Highlighted
[ Mon, Mar 24th ]: NDTV
IIT Bombay Launches Online PG Diploma In Computer Science And Engineering
[ Mon, Mar 24th ]: Digit
Jio, Airtel And Vi Offer JioHotstar Subscription .. ming With Plans Under Rs 250: Check Benefits Here
[ Mon, Mar 24th ]: TechRepublic
Fears Grow Over Delay of UK AI Safety Bill to Appease Trump Camp
[ Mon, Mar 24th ]: NextBigFuture
Huge Humanoid Bot News. China versus US Bot Makers
[ Mon, Mar 24th ]: AZoNano
Engineered Nanoclusters for Enhanced Stability in Hydrogen Evolution
[ Mon, Mar 24th ]: IGN
Real-Life Japanese Shrine That Appeared in Ghost .. After 'Grave and Unforgivable Act of Disrespect'
[ Mon, Mar 24th ]: Fortune
Inside the futuristic biotech startup Cellares th .. ng a cure for cancer with $355 million in funding
[ Mon, Mar 24th ]: MyJoyOnline
A letter to President John Mahama: Education! Education! Education!
[ Mon, Mar 24th ]: Axios
23andMe files for bankruptcy, will seek a buyer
[ Mon, Mar 24th ]: WION
Tech entrepreneur levels serious allegations agai .. st wife, Chennai police amid child custody battle
[ Mon, Mar 24th ]: Newspoint
ISRO YUVIKA 2025: ISRO has launched 'Young Scient .. oday, otherwise you will not get another chance..
[ Mon, Mar 24th ]: Zawya
STEM skills set to feature as major theme at Seatrade Maritime Logistics ME
[ Mon, Mar 24th ]: IOL
Libraries for sustainable communities: Pioneers of progress
[ Mon, Mar 24th ]: Moneycontrol
Mysterious glowing 'red sprites' lightning appears over Himalayas - What are they?
[ Mon, Mar 24th ]: CultureWatch
Technology, Transhumanism and Religion
[ Mon, Mar 24th ]: AZoAI
AI Researchers Sharpen Truth Detection with Fact-Level Hallucination Scanner
[ Mon, Mar 24th ]: SciTechDaily
A Hidden Shift in Dark Energy Could Rewrite the Laws of Physics
[ Mon, Mar 24th ]: YourStory
Rethinking life sciences research and innovation through integrated research campuses
Sun, March 23, 2025
[ Sun, Mar 23rd ]: Yahoo
West Valley School robotics team dives into preparations for world championship
[ Sun, Mar 23rd ]: TechRadar
I tested Gtech's first ever straightener, and it's a promising start from the vacuum king

Inside the futuristic biotech startup Cellares that's building a cure for cancer with $355 million in funding

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. cure-for-cancer-with-355-million-in-funding.html
  Print publication without navigation Published in Science and Technology on by Fortune
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Scoop ...Haun Ventures, the crypto venture giant that raised $1.5 billion across two funds back near the height of the last blockchain bull market in 2022, is out raising its second round of funds, which are set to total $1 billion. The raise is expected to close in June. I have all the details here.
Cellares, a biotech startup, has raised $255 million in Series C funding, bringing its total funding to $355 million, to revolutionize cancer treatment through automation. The company is developing the Cell Shuttle, an automated manufacturing platform designed to produce cell therapies at scale, aiming to reduce costs and increase accessibility. This platform automates the entire process from cell thawing to final product formulation, potentially allowing for the production of therapies in just a few days compared to weeks or months in traditional methods. Cellares' approach not only promises to make cell therapies more affordable but also aims to standardize the production process, which could lead to more consistent and reliable treatments. The funding will help expand their operations, including building a new manufacturing facility in Bridgewater, New Jersey, and scaling up their technology to meet the growing demand for personalized cancer treatments.

Read the Full Fortune Article at:
[ https://www.msn.com/en-us/money/companies/inside-the-futuristic-biotech-startup-cellares-that-s-building-a-cure-for-cancer-with-355-million-in-funding/ar-AA1BxAz9 ]